Recent Updates
Recently added Catalysts
BDX Positive Sentiment Score: 80/100

BD Board Increases Dividend for 54th Consecutive Year

Key Takeaway: BD (Becton, Dickinson and Company) has announced a quarterly dividend increase of 1.0% to $1.05 per share, marking the 54th consecutive year of dividend growth. This decision underscores the company's confidence in its long-term prospects, even amidst ongoing transactions. The annual dividend rate for fiscal year 2026 is set at $4.20 per share.

Market Sentiment Analysis

POSITIVE FACTORS

  • BD has increased its dividend for the 54th consecutive year.
  • The company maintains its status in the S&P 500 Dividend Aristocrats Index.
  • The dividend increase reflects confidence in BD's long-term outlook.
  • BD is committed to returning capital to shareholders.

Full Press Release Details

FRANKLIN LAKES, N.J.,Nov. 6, 2025/PRNewswire/ -- The Board of Directors of BD (Becton, Dickinson and Company) (NYSE:BDX) has declared a quarterly dividend of $1.05 per common share, an increase of 1.0% from the previous quarter. The dividend will be payable on December 31, 2025 to holders of record on December 8, 2025. The indicated annual dividend rate for fiscal year 2026 is $4.20 per share.
"This is the 54thconsecutive fiscal year in which we have raised our dividend, maintaining BD's membership in the S&P 500 Dividend Aristocrats Index, which tracks companies that have increased dividends for at least 25 consecutive years," said Tom Polen, chairman, CEO and president of BD. "This increase, even as we execute the Waters RMT transaction, reflects our confidence in our long-term outlook, as well as our ongoing commitment to create value and return capital to shareholders."
About BDBD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visitbd.comor connect with us on LinkedIn atwww.linkedin.com/company/bd1/, X (formerly Twitter)@BDandCoor Instagram@becton_dickinson.
SOURCE BD (Becton, Dickinson and Company)
Contacts:
Media: Investors:
Fallon McLoughlin Adam Reiffe
Director, Public Relations VP, Investor Relations
201.258.0361 201.847.6927
[email protected] [email protected]

Frequently Asked Questions

What is the new dividend amount declared by BD?

BD has declared a quarterly dividend of $1.05 per common share.

How many consecutive years has BD raised its dividend?

BD has raised its dividend for 54 consecutive years.

When will the new dividend be payable?

The new dividend will be payable on December 31, 2025.

What is the annual dividend rate for fiscal year 2026?

The indicated annual dividend rate for fiscal year 2026 is $4.20 per share.

Last updated: Nov 6, 2025